Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D002188:Cannabis / Q000494:pharmacology*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D002755:Choice Behavior / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology; D003463:Cues; D003975:Diazepam / Q000494:pharmacology; D004192:Discrimination, Psychological / Q000187:drug effects*; D013759:Dronabinol / Q000494:pharmacology*; D007649:Ketamine / Q000494:pharmacology; D007977:Levallorphan / Q000494:pharmacology; D008297:Male; D009020:Morphine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010622:Phencyclidine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011562:Psilocybin / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D014163:Transfer, Psychology / Q000187:drug effects; D015016:Yohimbine / Q000494:pharmacology
D011562:Psilocybin; D015016:Yohimbine; D007977:Levallorphan; D007649:Ketamine; D002707:Chlordiazepoxide; D009020:Morphine; D001285:Atropine; D013759:Dronabinol; D010830:Physostigmine; D000661:Amphetamine; D012601:Scopolamine; D010424:Pentobarbital; D003042:Cocaine; D010622:Phencyclidine; D003975:Diazepam; D002746:Chlorpromazine